百济神州(BGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BGNE 百济神州

盘前交易 08-11 07:22:53 EDT

184.71

+0.00

0.00%

最高184.71	最低184.71	成交量0.00
今开184.71	昨收184.71	日振幅0.00%
总市值196.66亿	流通市值118.16亿	总股本1.06亿
成交额6,143万	换手率0.00%	流通股本6,397万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BGNE","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":184.71,"timestamp":1735678800000,"preClose":184.71,"halted":8,"volume":0,"delay":0,"floatShares":63967877,"shares":106468226,"eps":-8.186614,"marketStatus":"盘前交易","change":0,"latestTime":"08-11 07:22:53 EDT","open":184.71,"high":184.71,"low":184.71,"amount":61429674.917619996,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.186614,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754919000000},"marketStatusCode":1,"symbolChange":{"newSymbol":"ONC","executeDate":"2025-01-02"},"adr":1,"adrRate":13,"exchange":"NASDAQ","adjPreClose":184.71,"volumeRatio":0},"requestUrl":"/m/hq/s/BGNE","defaultTab":"news","newsList":[{"id":"2500948271","title":"百济神州发布股份变动公告 增发65万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2500948271","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500948271?lang=zh_cn&edition=full","pubTime":"2025-01-02 17:38","pubTimestamp":1735810680,"startTime":"0","endTime":"0","summary":"财中社1月2日电百济神州 发布公告，内容涉及截至2024年12月31日的股份变动情况。公告显示，公司的已发行股份在此期间由12.69亿股增加至12.7亿股，增加数量为65万股。在具体的股份变动中，涉及发放的股份包括22万股用于授予非董事的股份奖励，3万股用于授予董事的股份奖励，以及39万股和7800股分别是因合资格参与者行使购股权而发行的普通股。2024年前三季度，百济神州-U实现收入191.36亿元，归母净利润-36.87亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501021740159858b4ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501021740159858b4ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2328871848.SGD","BK1500","06160","BGNE","BK1583","LU0307460666.USD","BK1588","LU1969619763.USD","688235","LU0588546209.SGD","ONC"],"gpt_icon":0},{"id":"2500840966","title":"百济神州因受限制股份单位获归属合共发行约25.65万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2500840966","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500840966?lang=zh_cn&edition=full","pubTime":"2025-01-02 09:25","pubTimestamp":1735781100,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　百济神州（06160）公布，2024年12月31日，因根据股权计划授出的受限制股份单位获归属（公司董事除外）而发行约22.31万股股份，因根据股权计划授出予公司董事的受限制股份单位获归属而发行约3.34万股股份。于2024 年12月 1 日至 2024 年12月31 日期间行使购股权而发行合共约39.4万股股份。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-01-02/doc-inecpvrz0599413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2328871848.SGD","BK4139","BK4526","BK1583","688235","BK4535","BK1500","BK4505","BK4548","LU0588546209.SGD","BK0239","BGNE","BK1161","06160","BK1588","BK4585","BK4504","LU0307460666.USD","LU1969619763.USD","BK4588"],"gpt_icon":0},{"id":"2500950976","title":"百济神州(06160)因受限制股份单位获归属合共发行约25.65万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2500950976","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500950976?lang=zh_cn&edition=full","pubTime":"2025-01-02 08:15","pubTimestamp":1735776911,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)公布，2024年12月31日，因根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行约22.31万股股份，因根据股权计划授出予公司董事的受限制股份单位获归属而发行约3.34万股股份。于2024 年12月 1 日至 2024 年12月31 日期间行使购股权而发行合共约39.4万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1232214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","LU1969619763.USD","BK1588","688235","BK4504","LU0588546209.SGD","BK4526","06160","BK4585","BK4139","LU0307460666.USD","BK1500","BK1583","BK0239","BK1161","BK4505","BK4535","BK4588","BK4548","BGNE"],"gpt_icon":0},{"id":"2495050699","title":"百济神州收盘上涨0.36%，最新市净率9.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2495050699","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495050699?lang=zh_cn&edition=full","pubTime":"2024-12-31 20:11","pubTimestamp":1735647095,"startTime":"0","endTime":"0","summary":"12月31日，百济神州今日收盘161.02元，上涨0.36%，最新市净率9.22。消息面上，百济神州11月13日接待AbcLife等127家机构调研，上市公司接待人员包括公司总裁、首席运营官、中国区总经理吴晓滨,高级副总裁、全球研发负责人汪来,大中华区首席财务官、全球技术运营财务负责人黄智,亚太区投资者关系负责人、信息披露境内代表周密。最新一期业绩显示，2024年三季报，公司实现营业收入191.36亿元，同比48.63%；净利润-3686694000.0元，同比4.94%，销售毛利率83.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123120143098566e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123120143098566e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU0588546209.SGD","BK1161","BK1588","LU1969619763.USD","LU2328871848.SGD","LU0307460666.USD","BK1500","688235","06160","BGNE"],"gpt_icon":0},{"id":"2495584126","title":"百济神州：百泽安在美国获批用于胃或胃食管结合部癌联合化疗的一线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2495584126","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495584126?lang=zh_cn&edition=full","pubTime":"2024-12-31 13:48","pubTimestamp":1735624080,"startTime":"0","endTime":"0","summary":"每经AI快讯，近日，百济神州宣布，美国食品药品监督管理局（FDA）已批准百泽安®（替雷利珠单抗）联合含铂和氟尿嘧啶类化疗用于肿瘤表达PD-L1（≥1）的不可切除或转移性HER2阴性胃或胃食管结合部（G/GEJ）癌成人患者一线治疗。（文章来源：每日经济新闻）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123113524995f39c05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123113524995f39c05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4526","BK4585","06160","BK4504","BK4505","BK4535","BGNE","BK4139","BK4588","688235"],"gpt_icon":0},{"id":"2495811306","title":"百济神州12月30日获南向资金加仓44.82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2495811306","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495811306?lang=zh_cn&edition=full","pubTime":"2024-12-31 09:30","pubTimestamp":1735608621,"startTime":"0","endTime":"0","summary":"12月30日, 南向资金增持百济神州44.82万股。截止当日收盘，港股通共持有百济神州7119.45万股，占流通股5.12%。港股通增持金额前五个股分别为工商银行、中芯国际、中国移动、农业银行、建设银行。百济神州近5个交易日上涨3.21%，港股通累计增持116.91万股；近20个交易日下跌10.64%，港股通累计增持515.86万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231093139a20fbc53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231093139a20fbc53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4504","06160","BGNE","BK4535","688235","BK4505","BK4548","BK4139","BK4588","BK4526","BK4585"],"gpt_icon":0},{"id":"2495351526","title":"美股异动丨百济神州盘前涨超1% 百泽安在美获批用于胃或胃食管结合部癌联合化疗的一线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2495351526","media":"格隆汇","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495351526?lang=zh_cn&edition=full","pubTime":"2024-12-30 17:29","pubTimestamp":1735550982,"startTime":"0","endTime":"0","summary":"百济神州(BGNE.US)盘前涨1.16%，报184美元。消息面上，百济神州近日宣布，美国食品药品监督管理局(FDA)已批准百泽安(替雷利珠单抗)联合含铂和氟尿嘧啶类化疗用于肿瘤表达PD-L1(≥1)的不可切除或转移性HER2阴性胃或胃食管结合部(G/GEJ)癌成人患者一线治疗。新适应症基于全球3期试验结果，证明百泽安联合化疗可显著改善晚期胃癌患者的总生存期。据悉，这是FDA在2024年授予百泽安的第二项批准。(格隆汇)","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/30172946944118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0588546209.SGD","BK4504","BK1500","BK1583","06160","LU2328871848.SGD","BK4526","BGNE","BK0239","BK4535","BK4139","LU1969619763.USD","LU0307460666.USD","BK4548","BK1161","688235","BK4585","BK4588","BK1588","BK4505"],"gpt_icon":0},{"id":"2495513161","title":"百济神州增发股份10万股 增幅0.007%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495513161","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495513161?lang=zh_cn&edition=full","pubTime":"2024-12-30 17:09","pubTimestamp":1735549740,"startTime":"0","endTime":"0","summary":"财中社12月30日电百济神州（688235/06160/BGNE）发布公告称，截止到2024年12月29日，公司已发行股份总数为12.69亿股，相较于2024年12月14日的12.69亿股，增加了10万股，增幅为0.007%。此次增发主要是由于根据股份计划授予参与人（非公司董事）的股份奖励而发行的新股。此外，公司在公告中提到截至2024年12月29日，库存在该日期内并未发生变化，仍为1.15亿股。此次股份变动均已获得董事会正式授权，并遵循相关上市规则及法律规定。2024年前三季度，百济神州-U实现收入191.36亿元，归母净利润-36.87亿元。（文章来源：财中社）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123017131595f269bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123017131595f269bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4585","BK4548","BK4139","06160","BK4588","688235","BK4504","BGNE","BK4526","BK4535"],"gpt_icon":0},{"id":"2495599061","title":"港股异动 | 百济神州(06160)涨超3% 百泽安®在美获批用于胃或胃食管结合部癌联合化疗的一线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2495599061","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495599061?lang=zh_cn&edition=full","pubTime":"2024-12-30 15:27","pubTimestamp":1735543661,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州(06160)涨超3%，截至发稿，涨3.28%，报110.1港元，成交额1.62亿港元。消息面上，12月27日晚，百济神州宣布，美国食品药品监督管理局（FDA）已批准百泽安®（替雷利珠单抗）联合含铂和氟尿嘧啶类化疗用于肿瘤表达PD-L1（≥1）的不可切除或转移性HER2阴性胃或胃食管结合部（G/GEJ）癌成人患者一线治疗。新适应症基于全球3期试验结果，证明百泽安®联合化疗可显著改善晚期胃癌患者的总生存期。据悉，这是FDA在2024年授予百泽安®的第二项批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1230748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1588","BK4548","BK4535","BK4526","BK4588","BK1161","LU1969619763.USD","06160","BK0239","BK1500","BGNE","LU2328871848.SGD","LU0588546209.SGD","BK4504","BK4505","BK4139","LU0307460666.USD","688235","BK4585"],"gpt_icon":0},{"id":"2495540025","title":"百济神州：12 月 29 日授出约 10.32 万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2495540025","media":"和讯网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495540025?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:51","pubTimestamp":1735519905,"startTime":"0","endTime":"0","summary":"【百济神州于 2024 年 12 月 29 日因股权计划授出的受限制股份单位获归属而发行约 10.32 万股股份】2024 年 12 月 29 日，百济神州公布了这一消息。此次发行约 10.32 万股股份是根据股权计划授出的受限制股份单位获归属而进行的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123009304095f1e5b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123009304095f1e5b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4526","BK4504","BK4139","BK4548","BK4505","06160","BK4585","BK4588","BGNE","BK4535"],"gpt_icon":0},{"id":"2495556667","title":"百济神州因受限制股份单位获归属而发行约10.32万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2495556667","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495556667?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:13","pubTimestamp":1735517580,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　百济神州（06160）公布，2024年12月29日，根据股权计划授出的受限制股份单位获归属（公司董事除外）而发行约10.32万股股份。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-30/doc-ineceyez4697222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4548","LU2328871848.SGD","LU1969619763.USD","BK4526","BGNE","LU0588546209.SGD","BK1161","BK4504","BK4585","BK1588","BK4588","LU0307460666.USD","BK4505","BK1583","BK4139","BK1500","BK4535","688235","BK0239","06160"],"gpt_icon":0},{"id":"2495455615","title":"【百济神州(06160.HK)因受限制股份单位获归属而发行约10.32万股股份】百济神州(06160.HK)公布，2024年12月29日，根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行约10.32万股股份。","url":"https://stock-news.laohu8.com/highlight/detail?id=2495455615","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495455615?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:10","pubTimestamp":1735517428,"startTime":"0","endTime":"0","summary":"百济神州(06160.HK)公布，2024年12月29日，根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行约10.32万股股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2024/12/30081046922185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1500","BK4535","BK4505","BK4526","BK4139","BK4548","BK1161","BK4585","LU0588546209.SGD","BK4504","BGNE","LU0307460666.USD","BK0239","LU1969619763.USD","LU2328871848.SGD","BK1588","06160","BK1583","688235","BK4588"],"gpt_icon":0},{"id":"2495563805","title":"百济神州(06160)因受限制股份单位获归属而发行约10.32万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2495563805","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495563805?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:07","pubTimestamp":1735517246,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)公布，2024年12月29日，根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行约10.32万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1230590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","BK4588","BK1588","BK4139","BK1161","BK4526","688235","LU0588546209.SGD","BGNE","06160","BK1500","BK0239","LU0307460666.USD","BK4535","LU1969619763.USD","LU2328871848.SGD","BK4505","BK4585","BK1583","BK4504"],"gpt_icon":0},{"id":"2494856587","title":"百济神州：光环之下，荆棘丛生","url":"https://stock-news.laohu8.com/highlight/detail?id=2494856587","media":"妙投APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494856587?lang=zh_cn&edition=full","pubTime":"2024-12-26 18:50","pubTimestamp":1735210252,"startTime":"0","endTime":"0","summary":"经过分析，虽然百济神州有多个光环，如创新实力较强，拥有国内首款年销售额超十亿美元的重磅新药泽布替尼；且凭借产品较好销售，自2022年起收入规模超越恒瑞医药的创新药收入，成为国内新的“创新药一哥”，风光无限。但光环之下，实则荆棘丛生。据不完全统计，通过一二级市场，百济神州这几年累计融资接近700亿元。但，百济神州扩大收入推进压力也不小。然而，百悦泽销售放量之下，忧","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226190414a20a5a6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226190414a20a5a6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BGNE","BK0239","688235","06160"],"gpt_icon":0},{"id":"2494369728","title":"中证沪港深500医药卫生指数下跌0.6%，前十大权重包含百济神州等","url":"https://stock-news.laohu8.com/highlight/detail?id=2494369728","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494369728?lang=zh_cn&edition=full","pubTime":"2024-12-26 15:37","pubTimestamp":1735198652,"startTime":"0","endTime":"0","summary":"数据统计显示，中证沪港深500医药卫生指数近一个月上涨0.51%，近三个月上涨11.01%，年至今下跌14.14%。从中证沪港深500医药卫生指数持仓样本的行业来看，化学药占比23.67%、生物药品占比22.20%、制药与生物科技服务占比16.73%、医疗器械占比15.09%、中药占比13.25%、医疗商业与服务占比9.06%。当中证沪港深500指数、中证沪港深互联互通中小综合指数和中证沪港深互联互通综合指数样本发生变动时，将进行相应调整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122615422095ed7c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122615422095ed7c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","06160","BGNE","000857.SH","BK0239"],"gpt_icon":0},{"id":"2494047505","title":"中证沪港深创新药产业指数下跌0.43%，前十大权重包含百济神州等","url":"https://stock-news.laohu8.com/highlight/detail?id=2494047505","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494047505?lang=zh_cn&edition=full","pubTime":"2024-12-25 20:46","pubTimestamp":1735130785,"startTime":"0","endTime":"0","summary":"金融界12月25日消息，上证指数高开震荡，中证沪港深创新药产业指数 下跌0.43%，报1574.16点，成交额104.7亿元。数据统计显示，中证沪港深创新药产业指数近一个月上涨0.78%，近三个月上涨12.11%，年至今下跌14.92%。该指数以2014年12月31日为基日，以1000.0点为基点。从中证沪港深创新药产业指数持仓样本的行业来看，医药卫生占比100.00%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/25204646817484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4526","LU0588546209.SGD","BK4535","BK4585","LU2328871848.SGD","BK4548","BK4588","LU1969619763.USD","BK4504","BK1161","159992","BK0239","LU0307460666.USD","06978","BGNE","BK1500","BK1588","BK1583","688235","BK4139","06160","BK1574","BK4505"],"gpt_icon":0},{"id":"2494771034","title":"百济神州上涨2.05%，报181.35美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2494771034","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494771034?lang=zh_cn&edition=full","pubTime":"2024-12-25 01:17","pubTimestamp":1735060620,"startTime":"0","endTime":"0","summary":"12月25日，百济神州(BGNE)盘中上涨2.05%，截至01:17，报181.35美元/股，成交1046.06万美元。财务数据显示，截至2024年09月30日，百济神州收入总额26.82亿美元，同比增长47.03%；归母净利润-4.93亿美元，同比增长4.13%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/25011746775688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1500","BK4585","LU0307460666.USD","BK4535","BK4588","LU0588546209.SGD","688235","BK1588","BK0239","06160","BK4548","BK4139","BK1161","LU2328871848.SGD","LU1969619763.USD","BGNE","BK4526","BK4505","BK4504"],"gpt_icon":0},{"id":"2493158086","title":"百济神州盘前涨约1.6% 拟变更美股代码 重申致力于提供创新肿瘤药物的承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=2493158086","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493158086?lang=zh_cn&edition=full","pubTime":"2024-12-24 17:28","pubTimestamp":1735032480,"startTime":"0","endTime":"0","summary":"百济神州(BGNE.US)盘前涨约1.6%，报180.53美元。消息面上，百济神州宣布，为反映公司在全球范围内致力于提供创新肿瘤药物的坚定承诺，在纳斯达克交易的美国存托股份的股票代码将由“BGNE”变更为“ONC”，自2025年1月2日起生效。(格隆汇)\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-12-24/doc-ineaqanq8435032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","LU0588546209.SGD","BK4535","BK1500","BK4526","LU2328871848.SGD","LU1969619763.USD","BK4548","BK1161","BK1588","688235","BK4139","BK4585","BK0239","BK4588","BK4504","BGNE","LU0307460666.USD","BK4505","06160"],"gpt_icon":0},{"id":"2493575816","title":"百济神州：纳斯达克股票代码变更为“ONC”","url":"https://stock-news.laohu8.com/highlight/detail?id=2493575816","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493575816?lang=zh_cn&edition=full","pubTime":"2024-12-23 19:30","pubTimestamp":1734953400,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，公司在纳斯达克交易的美国存托股份的股票代码将由“BGNE”变更为“ONC”，自2025年1月2日起生效，以彰显公司在全球范围内致力于提供创新肿瘤药物的坚定承诺。公司在香港联合交易所有限公司的股份代号及股份简称和上海证券交易所科创板的股票代码及证券简称将保持不变。纳斯达克股票代码变更无需公司股东采取任何行动即可实施。","market":"hk","thumbnail":"https://static.tigerbbs.com/23d76ef7beb21010ab2eeb1da862bc1e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/23d76ef7beb21010ab2eeb1da862bc1e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228574.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"百济神州：纳斯达克股票代码变更为“ONC”","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4007","LU2328871848.SGD","BK4585","BK0239","LU0588546209.SGD","BK4139","BK4535","BK1500","LU0307460666.USD","BGNE","BK4588","BK4505","LU1969619763.USD","BK4526","BK1161","06160","BK1588","BK1147","BK4548","BK4504","688235"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beigene.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.0092},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.021},{"period":"3month","weight":0.1291},{"period":"6month","weight":0.0606},{"period":"1year","weight":0.2008},{"period":"ytd","weight":0.0872}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BeiGene Ltd是一家全球生物技术公司，致力于为全球癌症患者发现和开发肿瘤治疗方法。该公司已发现并开发三种批准药物，包括BRUKINSA，一种布鲁顿酪氨酸激酶的小分子抑制剂，用于治疗各种血癌；TEVIMBRA（tislelizumab），一种抗PD-1抗体免疫疗法，用于治疗各种实体瘤和血癌；以及是聚ADP核糖聚合酶1(PARP1)和PARP2的选择性小分子抑制剂pamiparib。该公司已获得在美国、中华人民共和国（中国）、欧盟、英国、加拿大、澳大利亚和其他国际市场销售BRUKINSA，在欧盟和中国销售替雷利珠单抗，以及在中国销售帕米帕尼的批准。它还专注于在Amgen Inc独家授权下在中国商业化癌症药物，如XGEVA、BLINCYTO、KYPROLIS等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.062331},{"month":2,"riseRate":0.625,"avgChangeRate":0.017001},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.028933},{"month":4,"riseRate":0.444444,"avgChangeRate":0.028699},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.01513},{"month":6,"riseRate":0.555556,"avgChangeRate":0.015441},{"month":7,"riseRate":0.777778,"avgChangeRate":0.136456},{"month":8,"riseRate":0.555556,"avgChangeRate":0.036185},{"month":9,"riseRate":0.555556,"avgChangeRate":0.064683},{"month":10,"riseRate":0.555556,"avgChangeRate":0.004837},{"month":11,"riseRate":0.555556,"avgChangeRate":0.060012},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.03651}],"exchange":"NASDAQ","name":"百济神州","nameEN":"BeiGene"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(BGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(BGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,BGNE,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(BGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(BGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}